MYOD1 and neoplasm: In addition, the tumor was tested for MYOD1 (L122R) mutation by polymerase chain reaction (PCR), using forward and backward primers (8), followed by Sanger sequencing and was proved to be negative for MYOD1 (L122R) mutation (Figure 7).